From www.bloodjournal.org by guest on October 21, 2014. For personal use only. 1994 84: 2376-2378 Interpretation of X-chromosome inactivation patterns [letter; comment] RE Gale and DC Linch Updated information and services can be found at: http://www.bloodjournal.org/content/84/7/2376.citation.full.html Articles on similar topics can be found in the following Blood collections Information about reproducing this article in parts or in its entirety may be found online at: http://www.bloodjournal.org/site/misc/rights.xhtml#repub_requests Information about ordering reprints may be found online at: http://www.bloodjournal.org/site/misc/rights.xhtml#reprints Information about subscriptions and ASH membership may be found online at: http://www.bloodjournal.org/site/subscriptions/index.xhtml Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published weekly by the American Society of Hematology, 2021 L St, NW, Suite 900, Washington DC 20036. Copyright 2011 by The American Society of Hematology; all rights reserved. From www.bloodjournal.org by guest on October 21, 2014. For personal use only. 2376 CORRESPONDENCE Interpretation of X-Chromosome Inactivation Patterns To the Editor: We wish to comment on the recent paper by Fey et al’ using the M27P probe to detect clonality and X-chromosome inactivation patterns in hematopoietic cell populations. They p i n t out that the interpretation of the results in individual cases can be highly problematic, and we are in full agreement with this view. However, we would take issue with three points raised by these authors. Firstly, they say that ‘‘M27B discriminates less reliably between active and inactive alleles than phosphoglycerate kinase (PGK)and hypoxanthine phosphoribsyl transferase (HPRT)” and suggest that “Partial methylation of inactive X chromosomes . . . probably contributes to the apparent higher ascertainment of skewing in blood leukocytes [at the DXS255 locus].” However, the failure to completely digest either allele with Hpa I1 in hematologically normal or leukemic cell populations can be iargely overcome by the use of Hhal. and the results correlate well with those obtained using &aII.* The frequent skewing of X-chromosome inactivation patterns with M270 in normal blood cells is also seen as frequently with PGK and HPRT.’ Fey et al refer to a major lack of concordance between M27P and either PGK or HPRT in 5 of 48 samples, but in 3 of 5 samples, the excess skewing was not observed in the M27P analysis, but was observed when using PGK. In OUT studies, we observed good concordance between M27P and PGK or HPRT in 46 hematologically normal leukocyte samples (provided that all digested M270 bands were included)? Thus,we believe that the skewing of allele digestion with methylation-sensitive enzymes in normal leukocytes is not a methodologic artefact with M278, but a true reflection of X-chromosome inactivation. Secondly, they imply that their data is not compatible with the Lyon hypothesis and propose an alternative model. We do not be- lieve this is necessary or helpful. From the Lyon hypothesis, one would predict that if random X-chromosome inactivation occurred at a time when the hematopoietic stem cell pool was small, then skewing would be seen in a significant number of individuals (Fig 1, Table 1). The lesser degree of skewed X-chromosome inactivation patterns in other tissues found by Fey et al’ and ourselves6may then reflect a larger stem cell pool size for those tissues at the time of X-chromosome inactivation. This maymeanthat commitment to hematopoiesis has a restricted cell distribution in the embryo at the time of inactivation’; however, it is worth noting that in the mouse, X-chromosome inactivation is not complete in all tissues at the same time: which will similarly influence the patterns obtained. Thirdly, Fey et a1 refer to skewed patterns as nonrandom, but we believe that it is precisely because X-chromosome inactivation is random and occurs in a small stem cell pool that skewing occurs. If, in an individual with randomly skewed X-chromosome inactivation, a monoclonal tumor arises from a cell with the minor allele active, and if the tumor population is less than 90% pure, then Xchromosome inactivation ratios well below 10 can be seen. It can be particularly difficult to ensure such tumor purity in lymphoma samples where reactive lymphocytes are frequent. Consequently, suitable controls of normal tissue homologous to the tumor tissue of interest are not only a way around this problem, as they themselves point out, but are necessary to interpret X-chromosome inactivation patterns in individual cases. Fey et al have observed a greater degree of extreme skewing in leukocytes from normal individuals over the age of 75 years. In our studies, 4 of 12 (33%) females over the age of 75 had allelic cleavage ratios (ACR) > 10 in comparison with 4 of 73 (6%) between 20 and 58 years of age! However, it should be noted that in all four elderly individuals there was extreme skewing of rhe X-chromosome inactivation patrern in T cells as well as granu- From www.bloodjournal.org by guest on October 21, 2014. For personal use only. 2377 CORRESPONDENCE 40 I I 30 T. I 25- 0 - 16 cells 8 cells 4 cells 20 3020- v) P) 15 (D a 0 15- 20- *- 10 0 p 10- 10- 5 5- 0 I I 0 I I I I 25 I I I I I I I I 0- I 75 50 100 0 I 25 0 50 75 100 0 25 50 75 %A %A %A 37%' with 25 5 A 2 75% 1 8%' with 25 5 A 2 75% 5%* with 25 5 A 2 75% 1 I Fig 1. Expected distribution of random X-chromosome inactivation patterns according to stem cell pool size at the time of inactivation. *This figure representsthe sum total of cases with values <25% or >75% and half of those cases with values equal to 25% or 75%. locytes, and nonhematopoietic tissues from 2 of these 4, either muscle or skin and muscle, were also found to have imbalanced Xchromosome inactivation patterns. We believe that further studies in the elderly are warranted. Even if a higher degree of skewing is confirmed, this might represent selection of only a few clones and does not mitigate against the Lyon hypothesis. Rosemary E. Gale David C. Linch Department of Haematology University College London Medical School tondon, UK Table 1. Expected Proportionsof Patients With Skewed Patterns ~~~ 12 No. ofStem Cells at Time of X-Chromosome Inactivation ~75% or 6 2 5 % of Digested Alleles (ACR =3l 1 4 8 16 32 100 37 18 5 0.412 ~ ~91% or SS% of Digested Alleles (ACR 2 1 0 ) 100 1 0.044 0.0002 REFERENCES 1. Fey MF, Liechti-Gallati S , von Rohr A, Borisch B, Theilkas L, Schneider V, Oestreicher M, Nagel S, Ziemiecki A, Tobler A . Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27P DNA probe. Blood 83:931, 1994 2. Gale RE, Linch DC: Investigation of methylation at Hha I sites using the hypervariable probe M27P allows improved clonal analysis in myeloid leukaemia and demonstrates differences in methylation between leukaemic and remission samples. Leukemia 8:190,1994 3. Gale RE, Wheadon H, Linch DC: X-chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal andpost-chemotherapy females. Br J Haematol79:193,1991 4. Gale RE, Wheadon H, Linch DC: Assessment of X-chromosome inactivation patterns using the hypervariable probe M27P in normal hemopoietic cells and acute myeloid leukemic blasts. Leukemia 6549, 1992 5. Fey MF, Peter HJ, Hinds HL, Zimmermann A, Liechti-Galati S , Gerber H, Studer H. Tobler A: Clonal analysis of human tumors with M27P, a highly informative polymorphic X-chromosomal probe. J Clin Invest 89:1438, 1992 6. Gale RE, Wheadon H, Boulos P, Linch DC: Tissue specificity of X-chromosome inactivation patterns. Blood 83:2899, 1994 7. McLaren: Numerology of development. Nature 239:274, 1972 8. Tan S S , Williams EA, Tam PPL: X-chromosome inactivation occurs at different times in different tissues of the post-implantation mouse embryo. Nat Genet 3:170, 1993 Response We would like to thank Dr Belmont as well as D r S Gale and Linch for their interesting comments on our work on clonality and M27P X-inactivation patterns in hematology.' Dr Belmont suggests that our way of expressing the results of M27P X-inactivation analysis by calculating allelic cleavage ratios would lead to a distorsion of allelic cleavage ratio (ACR) values towards very large numbers as allelic contribution gets increasingly skewed.'.2 For practical reasons we have set the limits of the ACRs at l (lower end representing random X inactivation) and at 100 (upper end representing 100% unilateral use of one X chromosome) as outlined in Fig 2 of our paper.' As a corollary, an extreme distorsion of the results would be avoided. However, data compiled in this way were not normally distributed, and hence, nonparametric tests were chosen for statistical analysis. We share Dr Belmont's concern that our observations seem to undermine the correlation between X-chromosome activation status and particular methylation patterns at the M27P locus. His find- From www.bloodjournal.org by guest on October 21, 2014. For personal use only. 2378 ings of mismatches between results of M278 analysis and clonal analysis using the highly informative androgen receptor locus (HAR) are of particular interest in this r e ~ p e c tWe . ~ do not as yet have full results of HAR-X-inactivation analysis in our cases. However, our own preliminary data suggest that indeed correlation between clonal HAR and M278 analyses might not beconsistent in all cases (unpublished results). When comparing various approaches to study clonal X inactivation, we find it difficult to judge at this stage whether data obtained with M278 X-inactivation analysis are more likely to be inaccurate than results obtained with the phosphoglycerate kinase andthe hypoxanthine phosphoribosyl transferase gene polymorphisms, the HAR marker, or the glucose-6-phosphate-dehydrogenase protein variants. Unfortunately, the gold standard reflecting the true X-inactivation pattern of a particular case has notbeen defined. Therefore, we would certainly agree with Dr Belmont’s warning, which is also expressed in our paper, that results of M278 clonality assessment should be interpreted with great caution in hematologic or any other samples ifno homologous normal tissue control is available, because extreme skewing might be constitutional rather than reflecting the clonal neoplastic nature ofa cell population. Unfortunately, such control material is rarely if ever athand in hematologic cases. We have offered a few speculative explanations in our paper as to why skewedX inactivation might be more frequent at the M278 locus than at others, and Dr Belmont has thoughtfully extended our discussion on this interesting point. Although we cannot offer any formal proof, we still favor the hypothesis of a clonal succession model in hematopoiesis to explain age-related skewing in our patient population and we believe that Dr Belmont’s discussion of our findings may be taken as favoring the same basic idea. Drs Gale and Linch suggest that the problem of discriminating between active and inactive alleles at M27P maybe overcome by using Hha I instead of Hpa 11. We are grateful for this helpful comment and we are indeed currently testing our series of samples with Hha I. In a second comment, they p i n t out that the smaller the number of hematopoietic stem cells at the time of X inactivation, the higher the chances are for observing constitutionally skewed X inactivation inblood cells. If, for example, hematopoiesis would depend on a single stem cell, severe skewing would be seennot only in a clonal leukaemia from such an individual but equally in her normal leukocyte DNA. Assessment of clonality in such patients would obviously be problematic. Similarly, the degree of constitutive skewing in hematologic cell populations would increase over time if, with advancing patient age, hematopoiesis would depend on fewer and fewer actively dividing stem cells producing mature blood cells. Our data would support this notion. However, there isnoway to CORRESPONDENCE determine in a given normalindividual whether skewing at theM270 locus is caused by small size of the original hematopoietic stem cell pool present at thetime of lyonization or whether a clonal succession model might be responsible. Based on our observation of an increasingrate of skewing with advancing ageofthepopulationunder investigation, we believe that both ideas must be considered. However, it was never our intention, nor is it our current view that our data should be read as overthrowing Dr Mary Lyon’s X-inactivation hypothesis, andwe feel that this should appear clearly from our model shown in Fig 4.’ We were very interested to note that in their small series of elderly women, Gale et a14 were able to confirm our finding of an increased rate of severe skewing in blood leukocytes. We absolutely agree with their point that this phenomenon would warrant further investigation and we have never pretended that this finding, if confirmed, would mitigate in any way against the Lyon hypothesis. In summary, webelievethat although the M278 assay i s very usefulto assess clonality in solid tumors, its limitations for this purpose in hematology are such that its use should be discouraged. Martin F. Fey Albert von Rohr Institute of Medical Oncology Andreas Tobler Central Haematology Laboratory University of Berne Berne, Switzerland REFERENCES 1. Fey MF, Liechti-Gallati S, von Rohr A, Borisch B, Theilkas I, Schneider V, Oestreicher M, Nagel S, Ziemiecki A, Tobler A: Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M278 DNA probe. Blood 83:931, 1994 2. Fey MF, Peter HJ, Hinds HL, Zimmermann A, Liechti-Gallati S, Gerber H, Studer H, Tobler A: Clonal analysis of human tumours with M278,a highly informative polymorphic X-chromosomal probe. J Clin Invest 89:1438, 1992 3. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW: Methylation of Hpa I1 and Hha I sites near the polymorphic CAG repeat in the human androgen receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229, I992 4. Gale RE, Wheadon H, Boulos P, Linch DC: Tissue specificity of X-chromosome inactivation patterns. Blood 83:2899, 1994
© Copyright 2024